Skip to main content
PLOS One logoLink to PLOS One
. 2022 Sep 20;17(9):e0274978. doi: 10.1371/journal.pone.0274978

Socioeconomic inequalities in the risk factors of noncommunicable diseases (hypertension and diabetes) among Bangladeshi population: Evidence based on population level data analysis

Md Ashfikur Rahman 1,*
Editor: Jennifer Annette Campbell2
PMCID: PMC9488802  PMID: 36126087

Abstract

Background

Noncommunicable diseases (NCDs) such as hypertension and diabetes are among the most fatal disease and prevalent among the adult population worldwide, including Bangladesh, and pose a public health threat. Understanding the socioeconomic inequalities linked to NCD risk factors can aid in the development of effective strategies to reduce the disease’s recurrence. However, the literature on socioeconomic inequalities in hypertension and diabetes prevalence in Bangladesh is scant. Therefore, this study seeks to assess the inequality in hypertension and diabetes prevalence and to identify factors that may contribute to socioeconomic inequalities in Bangladesh.

Methods

The current study incorporated data from a recent round of Bangladesh Demographic and Health Survey (BDHS 2017–18). The age-standardized prevalence rates of hypertension and diabetes were reported, and the log-binomial regression technique was used to identify the relevant confounders. Additionally, socioeconomic inequalities were quantified using a regression-based decomposition technique in which the concentration index (CIX) and Concentration curve were produced to determine the socioeconomic factors contributing to inequality.

Results

Hypertension and diabetes were shown to have an age-standardized prevalence of (11.29% 95% CI: 11.13–11.69) and (36.98% 95% CI: 36.79–37.16), respectively. Both hypertension and diabetes were shown to be pointedly linked to the respondents’ age, wealth status, being overweight or obese, and a variety of respondents’ administrative divisions (p <0.001). In Bangladesh, household wealth status accounted for approximately 25.71% and 43.41% of total inequality in hypertension and diabetes, respectively. While BMI played a significant role in the emergence of inequality, the corresponding percentages for diabetes and hypertension are 4.95 and 83.38, respectively. In addition, urban areas contributed 4.56% inequality to increase diabetes among Bangladeshi inhabitants while administrative region contributed 4.76% of the inequality of hypertension.

Conclusion

A large proportion of Bangladesh’s adult population suffers from hypertension and diabetes. It is critical to recognize the value of equity-based initiatives in order to optimize the benefit-risk ratio and cost effectiveness of preventive health programmes. Integrating equity considerations into interventions is critical for policies and programmes to achieve their objectives. As a result, these findings can be taken into account when making existing and prospective policy decisions, as well as following its progression with economic development of Bangladesh.

Background

The United Nations and other international organizations promote and seek integrated approaches to the Sustainable Development Goals (SDGs), which attempt to address current global health inequalities through multi-sectoral maneuvers [1]. Five SDGs include explicit aims for reducing health disparities on a national and global scale. These objectives include poverty eradication, universal health and well-being, equitable education, gender equality, and the decrease of inequalities both within and between countries. The reduction of health inequalities and poverty reduction is the prominent promise of SDGs [2]. Therefore, addressing the health inequalities is important and it is gaining policy recognitions globally including developing country like Bangladesh.

The biggest threat to public health in the twenty-first century has continued to be noncommunicable diseases (NCDs), which result in ill health, mortality, and disability as well as economic loss, loss of life, declining living standards, and poor social development in both high- and low-income countries (LMICs) [35]. NCDs are expected to kill 41 million people each year, accounting for 71% of all mortality globally, with 77% of those deaths occurring in LMICs including Bangladesh [36]. Various infectious diseases are still common in Bangladesh, and they have long been the most significant contributors to disease burden, while the burden of noncommunicable diseases (NCDs) is also rising [7, 8] which is an ultimate threat to fulfil the country’s attainment of (SDG: 3.4). Which calls for 30% reduction in NCDs related mortality in the Global Action Plan for the Prevention and Control of NCDs through “prevention and treatment and promote mental health and well-being” [9, 10].

NCDs are becoming more prevalent as a result of socioeconomic inequalities not only in Bangladesh but also internationally [11]. NCDs share a number of behavioral risk factors, such as poor diet, excessive alcohol use, cigarette use, and sedentary lifestyles, all of which contribute to metabolic risk factors such as overweight and obesity, high blood pressure, high blood glucose, and high cholesterol [11]. These continue to be significant public health concerns in a number of developing countries. Hypertension, diabetes, tobacco use, dyslipidemia, overweight, and obesity have all been identified as a major risk factors for NCDs by researchers [8]. Taking into account the variations in outcome and exposure indicators, the burden of behavioral risk factors for NCDs is modified by socioeconomic features in resource-constrained settings [12]. Socioeconomic status has been established as a significant predictor of the distribution of NCD risk factors [13] which has resulted in an increased interest in measuring health care inequality [14]. Moreover, inadequate resources, an aging population, and a weak health system all pose significant impediments to eliminate the burden of NCDs [13]. The general interest in socioeconomic inequality in health extends beyond their quantification to comprehending and analyzing their underlying causes [15].

Despite efforts to enhance people’s lives and well-being, the burden of hypertension, diabetes, and other metabolic risk factors for NCDs continues to grow, with vast portions of the Bangladeshi population pleading for immediate action [4, 5, 1619]. Hypertension and diabetes are the major risk factors for cardiovascular disease(CVDs), afflicting approximately 1 billion individuals worldwide living with hypertension [15]. According to the International Diabetes Federation (IDF), 693 million adults worldwide are expected to have diabetes by 2045 if effective preventative efforts are not put into place. Approximately 80% of those with diabetes live in low- and middle-income countries [20, 21]. Studies also indicate that Asia and the Eastern Pacific region will experience the hardest hit by this disease by 2045 [22]. According to the World Health Organization (WHO), 8% of Bangladeshi adults had diabetes in 2016, accounting for approximately 3% of all deaths in the country [23]. However, a recent nationwide survey revealed an upsurge of the prevalence of (diabetes 10%) [18] and (hypertension 24%) [4] in males and women in Bangladesh [24]. Economic development in general may result in an increase in sedentary lifestyle or a decrease in physical activity levels as a result of demographic transition and increased life expectancy. It may also result in the adoption of Western lifestyles, resulting in a nutritional shift toward unhealthy food choices, such as increased intake of "fast foods" high in sugar and fat may contribute to increase the diabetes and hypertension prevalence in Bangladesh [35, 25].

Limited resources, substandard public health system, an uncontrolled private health sector, and an aging population all pose substantial barriers to effectively addressing Bangladesh’s escalating NCDs burden [13, 26]. In comparison to the plethora of evidence from high-income countries, there are comparatively few research on the link between socioeconomic position and NCDs in LMICs like Bangladesh. Previous studies demonstrated a disproportionate burden of several NCDs among rural low-income quintile populations and wealthier urban populations. The current study hypothesized that there is a significant variation in the distribution of contributing factors for NCDs by socioeconomic status. Based on the published literature, this study broke down inequality into a set of potential factors to determine their relative contributions. Therefore, this study attempts to measure the inequality of the prevalence of hypertension and diabetes, as well as identify factors that may contribute to socioeconomic inequalities in Bangladesh, using credible data. In addition, this study deconstructed inequality into a set of potential factors based on the existing literature in order to determine their respective contributions.

Methods

Data sources

The most recent Bangladesh Demographic and Health Survey (BDHS) dataset, 2017–18, was investigated in the study. The dataset was availed with appropriate application using DHS website. Between October 2017 and March 2018, the National Institute of Population Research and Training, Medical Education and Family Welfare Division, and the Ministry of Health and Family Welfare conducted the survey. The survey’s primary goal was to measure health indicators and offer an overview of population, maternal, and child health, as well as the status of several noncommunicable diseases (NCDs) such as hypertension and diabetes.

Study population and survey design

The 2017–18 BDHS used the complete list of enumeration areas (EAs) covering the total population of Bangladesh as its sampling frame. The survey used a list of enumeration areas (EAs) from the 2011 Population and Housing Census of the People’s Republic of Bangladesh given by the Bangladesh Bureau of Statistics. The primary sampling unit (PSU) of the survey is an EA that covers an average of 120 households in 2017–18. The 2017–18 BDHS was a multistage stratified cluster sample of household’s survey conducted in rural and urban settings, respectively. Rural wards were selected first, followed by PSUs, and then families were selected from PSUs. In urban areas, wards were selected using the PSUs technique, and each PSU had one EA. Then, households were picked from the sample of selected EAs. The final summary report of the 2017–18 BDHS contains a full discussion of the survey’s design, procedures, sample size, questionnaires, and conclusions. Anthropometry and BP were also systematically measured from the selected subsample of 2017–18 BDHS [24]. A total of 12, 290 sample and who were not pregnant considered in the analysis.

Outcome variables

Two outcome variables hypertension and diabetes were used for the analysis. Trained health technicians measured BP three times using digital oscillometric blood pressure measuring device monitor at about five minutes interval [24]. Then, the average of second and third measurements was used to report respondents’ final BP [24]. The American College of Cardiology/American Heart Association (ACC/AHA-2017) guidelines, individuals with a Systolic Blood Pressure (SBP of ≥130mmHg) and/or a Diastolic Blood Pressure (DBP of ≥80mmHg) or who were taking any prescribed antihypertensive drugs to control BP were categorized as hypertensive [27]. The Fasting Blood Glucose (FPG) (≥7.0) mmol/l (126 mg/dl) was classified as diabetes [28]. In addition, participants who were taking prescribed medications to lower their elevated blood glucose levels were classified as having diabetes [24].

Independent variables

The independent variables included in the study were selected based on previous literature reporting the risk of hypertension and diabetes in LMICs setting [4, 5, 8, 13, 17, 19, 2932]. The household factors included administrative divisions (Barisal, Chittagong, Dhaka, Khulna, Rajshahi, Rangpur, Sylhet, Mymensingh); place of residence (urban, rural); and wealth status (poorest, poorer, middle, richer, richest) based on pre-set cutoffs, whereas the socioeconomic and individual factors included: age of the participants (18–24, 25–34, 35–49, 50–59, 60–69, ≥70); sex of the participants (men, women); education level (no education, primary, secondary, higher); and occupational status (had no work, had work) and body mass index (BMI) level. We have used global cut-off points for BMI classification: underweight (<18.5kg/m2), normal (18.5–25.0kg/m2), overweight (25.1–29.9kg/m2), and obese (≥30.0 kg/m2) [33].

Conceptual framework

The distribution of different predictor variables and their combined effects have been shown in the (Fig 1). Despite strong associations between predictors and burden of NCDs (hypertension and diabetes) are separate entities, and each has an independent effect on outcomes [34]. To investigate the effects, it was hypothesized that several predictors (e.g., individual demographic factors, socioeconomic factors, geographical factors, lifestyle factors and intermediary factors BMI) were associated with developing outcomes (hypertension and diabetes) aligned with previously did studies elsewhere [3, 4, 5, 1518, 30, 31, 3546,] and the combination of predictors was expected to predict people’s health outcomes (hypertension and diabetes) [34].

Fig 1. Conceptual framework of the study.

Fig 1

Statistical analyses

Given the complexity of the BDHS survey, the data were pre-processed and weighted using savy command. Following that, the paper examined the normalcy assumption for continuous variables based on their distribution and reported it using medians and interquartile ranges (IQRs). Then, hypertension and diabetes were measured using age-standardised methods. As a result, the prevalence of hypertension and diabetes were normalized in the same standard population in order to eliminate or reduce the effect of participant age and sex distribution discrepancies. The selected explanatory variables were then fitted in an unadjusted log-binomial regression model. Following that, a log-binomial passion regression model with survey weights and explanatory variables with p-values (0.05) was used to identify risk factors for hypertension and diabetes, presenting results as adjusted incidence rate ratio(aIRR) and their 95% confidence intervals (CIs) and p-values. For data analysis, this study used Stata/MP 16 (StataCorp, College Station, Texas, USA).

Inequality measurement

The effects and contributions of various socioeconomic and demographic aspects of respondents to wealth-related disparity are shown using decomposition analysis. This technique can offer information on how hypertension and diabetes respond to changes in the determinant’s variable, which is important for prioritizing public health measures [18, 47]. To accomplish the objective of this study, the analyses were performed in several stages: plotting the concentration curves, examining the concentration indexes (CIs), and decomposition of the concentration index. To begin, we used concentration curves to look at how hypertension and diabetes prevalence differed by socioeconomic status. The cumulative percentage of respondents with hypertension and diabetes is plotted against the cumulative percentage of respondents according to their socioeconomic status on a concentration curve, which measures inequality (wealth index). The 45° line represents the equality line, indicating that there is no socioeconomic inequality in hypertension and diabetes. The presence of hypertension and diabetes is more concentrated among impoverished respondents if the concentration curve is above the equality line. If the concentration curve falls below the equality line, it means that the prevalence of hypertension and diabetes is unequally distributed among the upper (wealthy) class.

The concentration curve (CC) and concentration index (CIX) in their relative formulation (with no correction), were used to investigate the inequality in terms of hypertension and diabetes across analyzable socio-economic characteristics of the population [48]. The CIX in this study represents horizontal inequity, as each individual in the study was presumed to have an equal requirement. While constructing CC, the cumulative proportion of individual ranked according to their wealth index score (poorest first) was plotted against the cumulative proportion of hypertension and diabetes on the y-axis. The 45-degree slope from the origin revealed perfect equality. If the CC overlaps with the line of equality, hypertension and diabetes are equal among the population. However, if the CC subtends the line of equality below (above), then inequality in the use of hypertension and diabetes exists and is slanted towards individual belonging to low (high) socio-economic background. Further the CC subtends from the line of equality, the greater the degree of inequality. To evaluate the extent of wealth-related inequality, CIX was determined. CIX is widened as twice the region between the line of equality and CC [48].

The following are the advantages of using CIX as a measure of inequality index in healthcare: it takes socioeconomic dimension of hypertension and diabetes into account since the classification of individuals is according to the socioeconomic status, instead of their health status; it captures the experience of the whole population and; it is sensitive towards the changes in population distribution across socioeconomic groups. The CIX takes a value between − 1 and + 1. When the hypertension and diabetes are equally distributed across socioeconomic groups, CIX takes the value of 0. A positive value of CIX implies that hypertension and diabetes are concentrated among the higher socioeconomic groups (pro-rich). Conversely, a negative value of CIX suggests that hypertension and diabetes are concentrated among the lower socioeconomic groups (pro-poor). The calculation of CIX was done by using “convenient covariance” formula described by O’Donnell et al. [48], as shown in the Eq. 1 below.

CIX=2μcov(h,r) (1)

Here h is the health sector variable, μ is its mean, and r = i/N is the fractional rank of individual i in the living standards distribution, with i = 1 for the poorest and i = N for the richest. The user-written STATA commands Lorenz [49] and conindex [50] were used to produce CC and measure CIX, respectively.

Finally, the relative CIX was decomposed to determine the portion of inequality owing to the inequality in the underlying determinants. The findings were analyzed and interpreted using the technique described by Wagstaff et al. [51] and O’Donnell et al. [52]. The contribution of each determinant to overall wealth-related inequality is determined as the product of the determinant’s sensitivity to hypertension and diabetes (elasticity) and the degree of wealth-related inequality in that determinant (CIX of determinant). The residual is the portion of the CIX that is not explained by the determinants. The results of the decomposition method were reported in the following formats: elasticity, concentration index value, absolute contribution (same unit as the concentration index), and percentage (relative) contribution.

The "elasticity" column refers to the change in the dependent variable (socioeconomic inequality in hypertension and diabetes) that results from a one-unit change in the explanatory variables. A positive or negative sign in the elasticity denotes a rising or falling trend in hypertension and diabetes in association with a positive change in the determinants [47]. The distribution of the determinants in relation to the wealth quintiles is shown in the column "CI." The positive or negative sign of “CI” denotes whether the components were more concentrated in rich or poor households, respectively [18]. The percentage contribution indicates the relative contribution of each model component to the overall socioeconomic inequality in hypertension and diabetes. The observed socioeconomic inequality of hypertension and diabetes is increased by factors with positive percentage contributions. A negative percentage contribution, on the other hand, denotes a factor that is expected to lower the observed socioeconomic inequality in hypertension and diabetes [18].

Results

Background characteristics of study objects

A total of 12,290 were included in the final analysis, with 57.18% of them being women, 29.92% having primary education, 58.65% having a normal BMI, and 23.08% from Dhaka division. Approximately 73.47% lived in rural areas, and 32.71% were between the years of age 18–24 bracket (Table 1).

Table 1. General characteristics of the analyzable objects (unweighted).

Administrative Divisions Total (weighted) Poorest Poorer Middle Richer Richest
Barisal 666(5.51) 371(29.1) 282(22.05) 246(19.23) 200(15.64) 180(14.07)
Chittagong 2081(17.21) 187(11.23) 275(16.52) 337(20.24) 328(19.70) 538(32.31)
Dhaka 2790(23.08) 145(9.05) 170(10.61) 244(15.22) 441(27.51) 603(37.62)
Khulna 1511(12.50) 164(9.62) 327(19.18) 402(23.58) 411(24.11) 401(23.52)
Mymensingh 988(8.17) 384(27.53) 321(23.01) 300(21.51) 206(14.77) 184(13.19)
Rajshahi 1751(14.48) 290(17.98) 347(21.51) 398(24.67) 338(20.95) 240(14.88)
Rangpur 1514(12.53) 556(35.17) 350(22.14) 271(17.14) 198(12.52) 206(13.03)
Sylhet 788(6.52) 294(20.29) 263(18.15) 234(16.15) 294(20.29) 364(25.12)
Place of Residence
Urban 3207(26.53) 382(8.71) 376(8.57) 667(15.20) 1120(25.52) 1843(42.00)
Rural 8884(73.47) 2009(25.42) 1959(24.79) 1765(22.34) 1296(14.40) 873(11.05)
Sex of the Respondents
Male 5178(42.82) 1002 (18.93) 1009(19.06) 1060(20.03) 1059(20.01) 1163(21.97)
Women 6914(57.18) 1389(19.85) 1326(18.95) 1372(19.61) 1357(19.39) 1553(22.20)
Age of the Participants (years)
Median (IQR): 31.0 (23.0–43.0)
18–24 3955(32.71) 733(18.38) 740(18.56) 787(19.74) 832(20.87) 895(22.45)
25–34 2841(23.50) 575(19.84) 535(18.46) 568(19.60) 544(18.77) 676(23.33)
35–49 2052(16.97) 400(19.17) 412(19.74) 410(19.65) 420(20.12) 445(21.32)
50–59 1360(11.25) 260(18.77) 265(19.13) 285(20.58) 252(18.19) 323(23.32)
60–69 1062(8.79) 245(22.09) 225(20.29) 204(18.39) 218(19.66) 217(19.57)
≥70 818(6.77) 178(21.60) 158(19.17) 178(21.60) 150(18.20) 160(19.42)
BMI Level
Median (IQR): 21.44 (19.13–24.36)
Underweight (<18.5 kg/m2) 2066(17.28) 652(31.35) 517(24.86) 410(19.71) 302(14.52) 199(9.57)
Normal (18.5–25.0 kg/m2) 7014(58.65) 1450(20.37) 1429(20.08) 1498(21.05) 1452(20.40) 1288(18.10)
Overweight (25.1–29.9 kg/m2) 2388(19.97) 246(10.05) 321(13.11) 429(17.52) 536(21.90) 916(37.42)
Obesity (≥30.0 kg/m2) 489(4.09) 18(3.55) 33(6.51) 71(14.00) 96(18.93) 289(57.00)
Education Level
No Education 3114(25.75) 973(31.95) 738(24.24) 604(19.84) 446(14.65) 284(9.33)
Primary 3617(29.92) 913(24.68) 883(23.86) 776(20.97) 644(17.41) 484(13.08)
Secondary Education 3561(29.46) 420(11.87) 583(16.47) 751(21.22) 869(24.55) 916(25.88)
Higher 1798(14.87) 85(4.24) 131(6.53) 301(15.00) 457(22.78) 1032(51.45)
Working Status
Had no Work 4372(39.13) 713(14.70) 757(15.61) 938(19.34) 1028(21.20) 1413(29.14)
Had Work 7360(60.87) 1678(22.55) 1578(21.21) 1494(20.08) 1388(18.65) 1303(17.51)

BMI stands for Body Mass Index, IQR for Interquartile Range

Prevalence of diabetes and hypertension

Table 2 shows the age-standardized prevalence of having hypertension and diabetes among the sample population. The overall age-standardized prevalence of hypertension found (36.98% 95% CI: 36.79–37.16) and diabetes (11.29% 95% CI: 11.13–11.69). Diabetes was found to be somewhat more prevalent in women aged 18 or older (9.96% 95% CI: 9.83–10.08). The prevalence of diabetes and hypertension are substantially more prevalent among urban women (15.69% 95% CI: 15.45–15.93) and (38.65% 95% CI: 38.34–38.97) comparing to rural women. Diabetes prevalence was significantly higher among individuals aged 50–59 years. (17.85% 95% CI: 17.47–18.23) while hypertension found higher among the age 70+ or older. The diabetes and hypertension prevalence were higher among overweight and obesity BMI groups. Diabetes was found to be slightly more prominent among those who had completed secondary education. (11.05% 95% CI: 10.87–11.23) while hypertension found higher among the people who had no education (58.0% 95% CI: 56.2–59.7). The hypertension and diabetes prevalence increased with respondents’ wealth status. Highest prevalence of diabetes found among the two top wealth quantiles richest (20.27% 95% CI: 19.94–20.59) and richer (13.23% 95% CI: 12.94–13.52). While the hypertension found more common in richest group (41.71% 95% CI: 41.31–42.11). Across the divisions, diabetes found higher among the city dwellers of Dhaka (16.46% 95% CI: 16.06–16.87) and lowest in (7.00% 95% CI: 6.73–7.27).

Table 2. Age-standardized prevalence of diabetes and hypertension with corresponding 95% confidence interval (95% CI).

Diabetes Hypertension
Overall Prevalence 11.57(11.45–11.69) 36.98(36.79–37.16)
Administrative Divisions
Barisal 11.45(11.09–11.82) 42.00(41.44–42.57)
Chittagong 13.58(13.23–13.93) 39.49(39.00–39.99)
Dhaka 16.46(16.06–16.87) 31.13(30.62–31.63)
Khulna 11.54(11.22–11.86) 39.93(39.43–40.42)
Mymensingh 10.04(9.72–10.38) 33.23(32.72–33.75)
Rajshahi 9.82(9.51–10.14) 35.50(35.00–36.00)
Rangpur 7.00(6.73–7.27) 38.95(38.43–39.46)
Sylhet 12.75(12.38–13.13) 35.05(34.52–35.58)
Place of Residence
Urban 15.69(15.45–15.93) 38.65(38.34–38.97)
Rural 9.46(9.33–9.6) 36.12(35.9–36.35)
Sex of the Respondents
Men 9.71 (9.60–9.82) 26.34(25.87–27.41)
Women 9.96 (9.83–10.08) 28.61 (27.3–29.31)
Age of the Participants (years)
18–24 (RC) 4.43(4.27–4.6) 9.68(9.45–9.92)
25–34 9.9(9.65–10.14) 26.33(25.97–26.69)
35–49 13.43(13.14–13.73) 41.66(41.24–42.09)
50–59 17.85(17.47–18.23) 50.31(49.81–50.81)
60–69 14.59(14.22–14.98) 57.68(57.14–58.21)
≥70 14.22(13.83–14.62) 63.35(62.8–63.9)
BMI Level
Underweight (<18.5 kg/m2) 6.42(6.19–6.66) 28.41(27.99–28.84)
Normal (18.5–25.0 kg/m2) 9.52(9.37–9.67) 32.89(32.65–33.14)
Overweight (25.1–29.9 kg/m2) 16.84(16.54–17.13) 46.83(46.44–47.22)
Obesity (≥30.0 kg/m2) 20.35(19.73–20.98) 51.41(50.63–52.18)
Education Level
No Education 8.49 (8.35–8.63) 58.0 (56.2–59.7)
Primary 9.80 (9.65–9.96) 49.5 (47.9–51.1)
Secondary Education 11.05 (10.87–11.23) 48.4 (46.7–50.0)
Higher 10.79 (10.55–11.04) 50.7 (48.5–52.9)
Working Status
Had no Work 13.72(13.56–13.89) 41.57(41.33–41.81)
Had Work 8.37(8.21–8.54) 30.19(29.92–30.46)
Wealth status
Poorest 7.66(7.44–7.89) 33.47(33.07–33.86)
Poorer 6.6(6.39–6.82) 34.09(33.68–34.5)
Middle 9.14(8.9–9.39) 36.86(36.45–37.28)
Richer 13.23(12.94–13.52) 38.31(37.89–38.73)
Richest 20.27(19.94–20.59) 41.71(41.31–42.11)

Table 3, reports the adjusted and unadjusted log binomial passion distribution results. To interpret the findings researcher only discuss the adjusted incidence rate ratio (aIRR). The hypertension rate among the women individuals 1.13 times (aIRR: 1.13, 95% CI: 1.06–1.20; <0.001) high comparing to males. With age, the rate of hypertension increased while highest rate observed age ≥70 years or older 6.23 times (aIRR: 6.23, 95% CI: 5.25–7.03; <0.001). Diabetes rates have risen in line with the same age-related pattern. The rate of hypertension is 2.37–2.41 times higher in those with a BMI of 25.1–29.9 or ≥30 than in those with a BMI of less than 25. People with a BMI of 25.1–29.9—or 30—had 2.00- and 2.22-times risk of diabetes, respectively, as do those with a BMI of less than 25. The aIRR was much greater among individuals with some level of formal education. Individuals in the middle, upper, or uppermost quintiles of wealth had a greater aIRR than those in the poorest quintile for both hypertension and diabetes. In comparison to Dhaka, all of the surveyed divisions had lower aIRR for diabetes however, dissimilarities found in the hypertension rate. Alternatively, people who were engaged in any kinds of income-generating activities decreased the risk of having hypertension and diabetes.

Table 3. Factors associated with hypertension and diabetes: BDHS 2017–18.

Hypertension Diabetes
Administrative Divisions UIRR (95% CI) P-Value aIRR (95% CI) P-Value UIRR (95% CI) P-Value aIRR (95% CI) P-Value
Dhaka (RC) 1 1 1 1
Barisal 1.34(1.20–1.51) <0.001 1.28(1.45–1.43) <0.001 0.68(0.56–0.83) <0.001 0.77(0.63–0.94) 0.011
Chittagong 1.26(1.13–1.41) <0.001 1.21(1.09–1.35) <0.001 0.76(0.63–0.91) 0.002 0.75(0.63–0.90) 0.001
Khulna 1.27(1.14–1.42) <0.001 1.16(1.05–1.29) 0.004 0.61(0.50–0.74) <0.001 0.60(0.50–0.72) <0.001
Mymensingh 0.99(0.87–1.13) 0.894 1.03(0.92–1.17) 0.590 0.54(0.44–0.67) <0.001 0.68(0.55–0.85) 0.001
Rajshahi 1.16(1.03–1.30) 0.015 1.18(1.07–1.32) 0.002 0.58(0.48–0.70) <0.001 0.68(0.56–0.83) <0.001
Rangpur 1.29(1.16–1.45) <0.001 1.37(1.23–1.53) <0.001 0.41(0.33–0.52) <0.001 0.52(0.42–0.66) <0.001
Sylhet 1.08(0.96–1.22) 0.217 1.18(1.05–1.32) 0.004 0.67(0.55–0.81) <0.001 0.75(0.62–0.91) 0.003
Place of Residence
Rural (RC) 1 1 1
Urban 1.08(1.02–1.15) <0.001 1.01(0.95–1.07) 0.739 1.44(1.29–1.60) <0.001 0.99(0.88–1.12) 0.932
Sex of the Respondents
Male (RC) 1 1 1 1
Women 1.08(1.2–1.14) 0.010 1.13(1.06–1.20) <0.001 0.98(0.88–1.10) 0.784 0.95(0.83–1.09) 0.489
Age of the Participants (years)
18–24 (RC) 1 1 1 1
25–34 2.26(2.02–2.53) <0.001 2.11(1.88–2.37) <0.001 2.05(1.70–2.47) <0.001 1.97(1.62–2.39) <0.001
35–49 3.35(3.00–3.73) <0.001 3.21(2.86–3.60) <0.001 2.84(2.36–3.42) <0.001 2.91(2.38–3.54) <0.001
50–59 4.27(3.83–4.75) <0.001 4.31(3.84–4.84) <0.001 3.83(3.18–4.63) <0.001 3.96(3.24–4.84) <0.001
60–69 4.96(4.45–5.53) <0.001 5.21(4.64–5.85) <0.001 3.51(2.87–4.30) <0.001 3.96(3.19–4.92) <0.001
≥70 5.65(5.07-.29) <0.001 6.23(5.25–7.03) <0.001 3.46(2.78–4.31) <0.001 3.85(3.01–4.93) <0.001
BMI Level
Underweight (<18.5 kg/m2) (RC) 1 1 1 1
Normal (18.5–25.0 kg/m2) 1.35(1.22–1.45) <0.001 1.46(1.32–1.60) <0.001 1.52(1.25–1.85) <0.001 1.41(1.16–1.71) 0.001
Overweight (25.1–29.9 kg/m2) 2.30(2.08–2.54) <0.001 2.37(2.15–2.62) <0.001 2.70(2.21–3.31) <0.001 2.00(1.61–2.47) <0.001
Obesity (≥30.0 kg/m2) 2.49(2.19–2.84) <0.001 2.41(2.11–2.75) <0.001 3.57(2.78–4.58) <0.001 2.22(1.71–2.89) <0.001
Education Level
No Education (RC) 1 1 1 1
Primary 0.74(0.69–0.79) <0.001 1.00(0.93–1.07) 0.988 1.03(0.89–1.19) 0.671 1.25(1.08–1.46) 0.003
Secondary Education 0.65(0.60–0.70) <0.001 1.01(0.93–1.09) 0.826 1.02(0.88–1.18) 0.823 1.21(1.02–1.44) 0.027
Higher 0.66(0.60–0.72) <0.001 1.06(0.96–1.17) 0.245 1.06(0.90–1.26) 0.473 1.13(0.92–1.38) 0.251
Working Status
Had no Work (RC) 1 1 1 1
Had Work 0.79(0.75–0.84) <0.001 0.92(0.86–0.98) 0.010 0.73(0.66–0.82) <0.001 0.83(0.72–0.95) 0.007
Wealth Status
Poorest (RC) 1 1 1 1
Poorer 1.09(0.98–1.20) 0.099 1.06(0.97–1.17) 0.201 1.02(0.81–1.28) 0.889 0.97(0.77–1.22) 0.777
Middle 1.18(1.07–1.30) 0.001 1.11(1.01–1.22) 0.023 1.28(1.11–1.70) 0.003 1.22(0.98–1.52) 0.075
Richer 1.27(1.16–1.40) <0.001 1.17(1.06–1.29) 0.001 1.90(1.56–2.32) <0.001 1.53(1.24–1.91) <0.001
Richest 1.48(1.35–1.61) <0.001 1.18(1.07–1.31) 0.001 3.06(2.55–3.67) <0.001 2.15(1.73–2.68) <0.001

RC stands for Reference Category, UIRR means Unadjusted incidence rate ratio, AIRR means Adjusted incidence rate ratio

Inequality in hypertension and diabetes

The concentration curve and concentration index were used to estimate and to show the inequalities in hypertension and diabetes among Bangladeshi individuals (Figs 2 & 3). In both situations, the concentration curve is located below the line of equality (45° line), indicating a larger concentration of hypertension and among individuals from the top wealth quintiles than among the rest of the population. This study revealed that the values of the CIX for hypertension and diabetes were (CIX: 0.06388445 (p<0.001) and (CIX: 0.24727198 (p<0.001), respectively, for hypertension and diabetes (Figs 2 & 3). Hence, among Bangladeshi households with greater socioeconomic standing, this study discovered a pro-rich socioeconomic inequality for hypertension and diabetes.

Fig 2. Concentration curve for hypertension over wealth status.

Fig 2

Fig 3. Concentration curve for diabetes over wealth status.

Fig 3

Decomposition of concentration index for hypertension and diabetes

Table 4 demonstrates the effects of several socioeconomic and demographic determinants on hypertension and diabetes inequities. The column ’Elasticity’ indicates the amount of change in the dependent variable (socioeconomic inequality in hypertension and diabetes) that occurs when the explanatory factors change by one unit. Elasticity with a positive or negative sign implies an increasing or decreasing trend in diabetes or hypertension in conjunction with a positive change in the factor [18, 47]. The distribution of the determinants in terms of wealth quintiles is shown by the column ’CIX.’ The positive or negative direction of the CI signifies that the factors were more concentrated in either wealthy or impoverished groups. The percentage contribution illustrates how much each determinant in the model contributes to overall socioeconomic inequalities. A positive percentage contribution means a factor contributes to increase observed socioeconomic disparities of hypertension and diabetes. A negative percentage contribution, on the other hand, denotes a factor that is expected to reduce hypertension and diabetes-related socioeconomic inequalities. In Bangladesh, household wealth status accounted for roughly 25.71% an 43.41% of the overall inequality in hypertension and diabetes, respectively. While BMI made a significant impact to the establishment of inequality concentration, it was 4.95 and 83.38% for hypertension and diabetes, correspondingly. Furthermore, urban areas were responsible for 4.56% of the intensification in diabetes among Bangladeshi residents, while administrative regions were responsible for 4.76% of the hypertension inequality. While educational status accounts for 7.23% and 0.89% of hypertension and diabetes inequality in Bangladeshi adults, respectively. The unexplained or residual contributing factors to the socioeconomic inequalities in hypertension and diabetes accounted for (-38. 58%) and (-62.14%), respectively.

Table 4. Decomposition of concentration index for measuring socioeconomic inequalities in hypertension and diabetes.

Hypertension Diabetes
Contribution to overall CIX = 0.06388445 (p<0.001) Contribution to overall CIX = 0.24727198 (p<0.001)
Elasticity CIX Absolute contribution Percentage contribution Elasticity CIX Absolute contribution Percentage contribution
Administrative Divisions
Dhaka (RC)
Barisal .01449863 -.23288488 -.00337651 -5.2853415 -.00551451 -.23288488 .00128425 .51936546
Chittagong .03011325 .12439611 .00374597 5.8636667 -.0172004 .12439611 -.00213966 -.86530734
Khulna .01850648 .05179982 .00095863 1.500572 -.02543476 .05179982 -.00131752 -.5328206
Mymensingh .00314632 -.21009727 -.00066103 -1.0347312 -.01129641 -.21009727 .00237335 .95981164
Rajshahi .02980763 -.09989361 -.00297759 -4.6609016 -.02127521 -.09989361 .00212526 .85948189
Rangpur .0430925 -.29738631 -.01281512 -20.059844 -.03104046 -.29738631 .00923101 3.7331395
Sylhet .01269142 -.02917272 -.00037024 -.57955149 -.0070774 -.02917272 .00020647 .08349791
Subtotal -24.25613109 0.01176316 4.75716846
Place of Residence
Urban -.0213918 -.13629789 .00291566 4.5639544 .0010518 -.13629789 -.00014336 -.05797604
Rural (RC)
Sex of the Respondents
Male (RC)
Women -.05691692 .00645033 -.00036713 -.57468238 .02431801 .00645033 .00015686 .06343585
Age of the Participants (years)
18–24 (RC)
25–34 .13745838 .00559709 .00076937 1.2043098 .0594244 .00559709 .0003326 .13450922
35–49 .16758381 -.00867759 -.00145422 -2.2763347 .0720604 -.00867759 -.00062531 -.25288378
50–59 .15242511 -.00836368 -.00127483 -1.995532 .05990346 -.00836368 -.00050101 -.20261629
60–69 .14061338 -.05352401 -.00752619 -11.780945 .04830372 -.05352401 -.00258541 -1.0455729
≥70 .12281228 -.03691302 -.00453337 -7.0962063 .03402716 -.03691302 -.00125605 -.507961
Subtotal -0.01401924 -21.9447082 -0.00463518 -1.87452475
BMI Level
Underweight (<18.5 kg/m2) (RC)
Normal (18.5–25.0 kg/m2) .23974132 -.03916543 -.00938957 -14.697743 .05802614 -.03916543 -.00227262 -.91907665
Overweight (25.1–29.9 kg/m2) .19997692 .22286179 .22286179 69.762229 .04395601 .22286179 .00979611 3.9616758
Obesity (≥30.0 kg/m2) .04159134 .43494286 .01808986 28.316526 .01086356 .43494286 .00472503 1.910862
Subtotal 0.23156208 83.381012 0.01224852 4.95346115
Education Level
No Education (RC)
Primary .00031321 -.13044191 -.00004086 -.06395154 .03157589 -.13044191 -.00411882 -1.6657043
Secondary Education .00900482 .12892804 .00116097 1.8173017 .02514205 .12892804 .00324151 1.3109106
Higher .0087813 .39811928 .00349601 5.4723897 .00775496 .39811928 .0030874 1.2485847
Subtotal 0.00461612 7.22573986 0.00221009 0.893791
Working Status
Had no Work (RC)
Had Work .00352467 5.5172578 -.06522455 -.06928569 .00451913 1.8275942 .00451913 1.8275942
Wealth status
Poorest (RC)
Poorer .00408401 -.41556635 -.00169718 -2.6566357 -.00230154 -.41556635 .00095644 .38679727
Middle .00984568 -.01167131 -.00011491 -.17987477 .01308682 -.01167131 -.00015274 -.00015274
Richer .01978422 .39371194 .00778928 12.192768 .0330336 .39371194 .01300572 5.2596837
Richest .02731484 .7964429 .02175471 34.05322 .06229847 .7964429 .04961718 20.065831
Subtotal 0.0277319 43.40947753 0.0634266 25.71215923
Explained CI 138.58018379 38.14417404
Residual CI -38. 58018379 -62. 14417404

BMI Stands for Body Mass Index, RC is to Reference Category, CIX means Concentration Index.

Discussion

The current study investigated the socioeconomic inequalities associated with metabolic and behavioural risk factors for hypertension and diabetes in the Bangladeshi population using the most recent demographic and health survey data. Socioeconomic inequality analysis has developed into a critical instrument for influencing policy decisions that are driven by inequities. The analysis found that diabetes and hypertension are more common and concentrated among the richest Bangladeshis living in urban areas, and their incidence is noticeably higher than in the last round of research. The pro-rich socioeconomic inequalities in hypertension and diabetes were significantly influenced by household wealth status, administrative region, being overweight or obese, employment status, and living in metropolitan areas. A report published in 2013 elsewhere documented that persons who live in impoverished or disadvantaged communities face a greater risk of death from non-communicable diseases than those who reside in more advantaged groups and communities [53]. In eleven European countries, a study found that ischemic heart disease is more prevalent in lower socioeconomic groups, in contrast to India, where cardiovascular illness and cardio-metabolic risk factors are more prevalent in higher socioeconomic groups [36, 54, 55]. Although another study in Southeast Asia found that a disproportionate number of unfavourable risk factors for NCDs are concentrated in impoverished groups [37]. According to a study comprising 41 low- and middle-income nations, wealth and education were found to be inversely connected to numerous NCDs, and poorer socioeconomic position may be responsible for raising the risk of NCD mortality [56, 57].

The age-adjusted prevalence of hypertension and diabetes are significantly lower among the people from less socioeconomic status than higher socioeconomic status (see Table 3), which is consistent with earlier studies elsewhere [4, 5, 15]. Economic development, in general, may result in an increase in sedentary lifestyle or a decrease in physical activity levels. It may also result in the adoption of Western lifestyles, resulting in a nutritional shift toward unhealthy food choices, such as increased intake of "fast foods" high in sugar and fat, both of which are known risk factors for overweight/obesity [58]. While overweight and obesity are risk factors for hypertension and diabetes [4, 5, 31, 59, 60]. However, due to increased access to health information and resources, there may be reduced burdens associated with behavioral and metabolic risk factors for NCDs among advantaged individuals [15]. Socioeconomic inequalities among NCD risk factors may be a result of previous interventions’ inability to employ equity-based techniques for their reduction, as various populations may have varying levels of engagement in health programs or behavior change communication [4, 5, 16, 17, 59].

The chief findings of the study are that household wealth status accounted for approximately 25.71 and 43.41% of total inequality in hypertension and diabetes, respectively, in Bangladesh. While BMI contributed the substantial contribution to the inequality formation is 4.95 and 83.38%, respectively for hypertension and diabetes. In addition, urban areas contributed 4.56% inequality to increase diabetes among Bangladeshi inhabitants while administrative region contributed 4.76% of the inequality of hypertension. Similar findings have been reported in a variety of situations, demonstrating that those in the highest socioeconomic backgrounds are more likely to have diabetes and hypertension [18, 30, 61]. Due to a lack of access to health care, inadequate diabetes and blood pressure screening tools, lack of education, societal stigma, and inadequate health systems, a sizable section of the population remains undiagnosed [38, 40].

Obesity and overweight contributed 83.38% percent and 4.95%, to the total inequality in diabetes and hypertension, respectively. Along with contributing significantly to socioeconomic inequalities in the prevalence of diabetes and hypertension [18, 38, 62]. Of late, a rising trend toward becoming overweight or obese has recently been documented among Bangladesh’s urban and affluent residents [6264]. Obesity and overweight rates are rising because of causes such as the decline in physical activity owing to technologically intense job, watching television, using social media and the internet, and others. Another factor contributing to overweight and obese is the fact that those from affluent household in low-income nations are less likely to engage in physical activity, having much leisure times, which in turn results in greater weight gain and disease risk [35, 65]. Because physical activity frequently boosts oxygen consumption throughout the body and maintains blood glucose levels to protect the central nervous system, it may help minimize the risk of diabetes and other noncommunicable diseases [18, 44].

Additionally, this study found that geographical variations in diabetes contributed considerably to diabetes inequality. Although the causes for this are unknown, certain places are predicted to have a disproportionately high rate of undiagnosed diabetes [40]. Though there were no significant socioeconomic differences had found for all divisions. Rangpur division contributed 3.73% inequality. This could be because of socioeconomic inequalities such as limited resources, income inequality, low level of education and social safety net programs, poor connectivity with the urban centres, distance of health facilities, fragile communication system and insufficiency or absence public facilities [4, 13, 66]. As a result, adopting administrative region-specific policies for addressing hypertension and diabetes in such areas should be addressed [18]. Further research on the risk factors that contribute to these geographical inequalities in Bangladesh is necessary.

According to the findings, achieving the target of halving premature NCD mortality in Bangladesh by 2030 may be attainable by leveraging development expenditures. Understanding the pattern of socioeconomic inequalities in risk factors for NCDs could aid in improving NCD preventive, development, and poverty reduction efforts, which are critical components of the global action plan for NCD prevention and control [15, 67]. The clear evidence that NCD risk factors influence disadvantaged individuals of LMICs may prompt development agencies dealing with these populations to alter their programs to address NCDs. The study’s findings highlight the critical need for disaggregated data, which was stressed during the United Nations High Level Meeting on Noncommunicable Diseases [39]. The stage of economic growth, cultural factors, social, and health policies may all influence the socio-economic gradient of inequalities in NCD risk factors. People who live in distant or difficult-to-reach communities, as well as those with poor socioeconomic position, may have less access to health care for early diagnosis and treatment of NCDs than those who live in urban areas or have a higher socioeconomic status. Additional research on the emergence of inequality in chronic NCDs through time, as well as on the sociodemographic factors that drive inequality, is necessary to have a better understanding of the underlying causes and reasons for the current distribution of chronic NCDs in Bangladesh. The social and environmental factors that contribute to Bangladesh’s inequitable distribution of disease have not been stated explicitly, and must be further investigated in view of the obvious prevalence of disparities between urban and rural areas.

The study’s strengths and limitations are acknowledged. The study’s strength is its generalizability to Bangladesh, as the analysis included nationally representative data from all divisions. Along with appropriate statistical methods for estimating the age-standardized prevalence of hypertension and diabetes in the sample, decomposition of the inequality measure and Lorenz estimates were performed using standard approaches. However, our study has some certain shortcomings. Due to the study’s cross-sectional methodology, no causal association between risk factors could be established. Additionally, other risk factors (such as dietary habits, physical activity, family history of non-communicable diseases, and alcohol and smoking usage) were omitted from the data collection process might influence the study results. Therefore, further detailed cohort study is warranted.

Conclusions

The present study concludes that diabetes and hypertension are more widespread in Bangladesh’s urban areas among the well-off individuals. It is recognized that inequalities in wealth distribution and geographic location contribute to the burdens associated with NCDs risk factors. This obvious distinction highlights the importance of creating focused intervention strategies to address the growing problem of NCDs and associated risk factors in these groups.

Data Availability

This study used publicly available Demographic and Health Surveys Program datasets from Bangladesh, which can be freely obtained from https://dhsprogram.com/. As a third party users the authors do not have permission to share the data.

Funding Statement

The author(s) received no specific funding for this work.

References

  • 1.Niessen LW, Mohan D, Akuoku JK, Mirelman AJ, Ahmed S, Koehlmoos TP, et al. Tackling socioeconomic inequalities and non-communicable diseases in low-income and middle-income countries under the Sustainable Development agenda. Lancet. 2018;391: 2036–2046. doi: 10.1016/S0140-6736(18)30482-3 [DOI] [PubMed] [Google Scholar]
  • 2.Evans DB, Marten R, Etienne C. Universal health coverage is a development issue. Lancet. 2012;380: 864–865. doi: 10.1016/S0140-6736(12)61483-4 [DOI] [PubMed] [Google Scholar]
  • 3.Rahman M, A., Halder HR, Kundu S, Sultana F, Mohammed S, Islam S. Trends in the prevalence and associated factors of prediabetes and diabetes in Bangladesh: Evidence from population-based cross-sectional surveys. 2022. [DOI] [PubMed] [Google Scholar]
  • 4.Rahman MA, Halder HR, Yadav UN, Mistry SK. Prevalence of and factors associated with hypertension according to JNC 7 and ACC/AHA 2017 guidelines in Bangladesh. Sci Rep. 2021;11: 1–10. doi: 10.1038/s41598-021-94947-2 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.Rahman MA, Parvez M, Halder HR, Yadav UN, Mistry SK. Prevalence of and factors associated with prehypertension and hypertension among Bangladeshi young adults: An analysis of the Bangladesh Demographic and Health Survey 2017–18. Clin Epidemiol Glob Heal. 2021;12: 100912. doi: 10.1016/j.cegh.2021.100912 [DOI] [Google Scholar]
  • 6.World Health Organization. Noncommunicable diseases: Progress monitor 2020. 2020.
  • 7.Khan JAM, Trujillo AJ, Ahmed S, Siddiquee AT, Alam N, Mirelman AJ, et al. Distribution of chronic disease mortality and deterioration in household socioeconomic status in rural Bangladesh: an analysis over a 24-year period. Int J Epidemiol. 2015;44: 1917–1926. doi: 10.1093/ije/dyv197 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.Khalequzzaman M, Chiang C, Choudhury SR, Yatsuya H, Al-Mamun MA, Al-Shoaibi AAA, et al. Prevalence of non-communicable disease risk factors among poor shantytown residents in Dhaka, Bangladesh: A community-based cross-sectional survey. BMJ Open. 2017;7: e014710. doi: 10.1136/bmjopen-2016-014710 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Bennett JE, Stevens GA, Mathers CD, Bonita R, Rehm J, Kruk ME, et al. NCD Countdown 2030: worldwide trends in non-communicable disease mortality and progress towards Sustainable Development Goal target 3.4. Lancet. 2018;392: 1072–1088. doi: 10.1016/S0140-6736(18)31992-5 [DOI] [PubMed] [Google Scholar]
  • 10.World Health Organization. WHO | Global Action Plan for the Prevention and Control of NCDs 2013–2020. Geneva, Switzerland; 2013. Available: https://www.who.int/nmh/events/ncd_action_plan/en/
  • 11.Riley L, Gouda H, Cowan M. Noncommunicable Diseases Progress Monitor. World Health Organization. 2017. Available: http://apps.who.int/iris/bitstream/10665/258940/1/9789241513029-eng.pdf [Google Scholar]
  • 12.Allen L, Williams J, Townsend N, Mikkelsen B, Roberts N, Foster C, et al. Socioeconomic status and non-communicable disease behavioural risk factors in low-income and lower-middle-income countries: a systematic review. Lancet Glob Heal. 2017;5: e277–e289. doi: 10.1016/S2214-109X(17)30058-X [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.Biswas T, Islam MS, Linton N, Rawal LB. Socio-economic inequality of chronic non-communicable diseases in Bangladesh. PLoS One. 2016;11: e0167140. doi: 10.1371/journal.pone.0167140 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.Heckley G, Gerdtham U-G, Kjellsson G. A general method for decomposing the causes of socioeconomic inequality in health. J Health Econ. 2016;48: 89–106. doi: 10.1016/j.jhealeco.2016.03.006 [DOI] [PubMed] [Google Scholar]
  • 15.Yaya S, Uthman OA, Ekholuenetale M, Bishwajit G. Socioeconomic inequalities in the risk factors of noncommunicable diseases among women of reproductive age in sub-Saharan Africa: A multi-country analysis of survey data. Front Public Heal. 2018;6: 1–11. doi: 10.3389/fpubh.2018.00307 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.Rahman MM, Gilmour S, Akter S, Abe SK, Saito E, Shibuya K. Prevalence and control of hypertension in Bangladesh: a multilevel analysis of a nationwide population-based survey. J Hypertens. 2015;33: 465–472. doi: 10.1097/HJH.0000000000000421 [DOI] [PubMed] [Google Scholar]
  • 17.Riaz BK, Islam MZ, Islam ANMS, Zaman MM, Hossain MA, Rahman MM, et al. Risk factors for non-communicable diseases in Bangladesh: Findings of the population-based cross-sectional national survey 2018. BMJ Open. 2020;10: 1–11. doi: 10.1136/bmjopen-2020-041334 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18.Sarker AR, Khanam M. Socio-economic inequalities in diabetes and prediabetes among Bangladeshi adults. Diabetol Int. 2021. doi: 10.1007/s13340-021-00556-9 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19.Khan MN, Oldroyd JC, Chowdhury EK, Hossain MB, Rana J, Renzetti S, et al. Prevalence, awareness, treatment, and control of hypertension in Bangladesh: Findings from National Demographic and Health Survey, 2017–2018. J Clin Hypertens (Greenwich). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20.Islam SMS, Purnat TD, Phuong NTA, Mwingira U, Schacht K, Fröschl G. Non‐Communicable Diseases (NCDs) in developing countries: a symposium report. Global Health. 2014;10: 1–8. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21.Cho N, Shaw JE, Karuranga S, Huang Y da, da Rocha Fernandes JD, Ohlrogge AW, et al. IDF Diabetes Atlas: Global estimates of diabetes prevalence for 2017 and projections for 2045. Diabetes Res Clin Pract. 2018;138: 271–281. doi: 10.1016/j.diabres.2018.02.023 [DOI] [PubMed] [Google Scholar]
  • 22.IDF. IDF Diabetes Atlas | Tenth Edition. [cited 20 Dec 2021]. Available: https://diabetesatlas.org/
  • 23.International Diabetes Federation (IDF). IDF Diabetes Atlas | Tenth Edition. [cited 24 Jan 2022]. Available: https://diabetesatlas.org/
  • 24.National Institute of Population Research and Training (NIPORT), ICF International. Bangladesh Demographic and Health Survey 2017–18. Dhaka, Bangladesh, and Rockville, Maryland, USA; 2020. Available: https://dhsprogram.com/pubs/pdf/PR104/PR104.pdf
  • 25.Agho KE, Osuagwu UL, Ezeh OK, Ghimire PR, Chitekwe S, Ogbo FA. Gender differences in factors associated with prehypertension and hypertension in Nepal: A nationwide survey. PLoS One. 2018;13: e0203278. doi: 10.1371/journal.pone.0203278 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 26.Islam A, Biswas T. Health system in Bangladesh: challenges and opportunities. Am J Heal Res. 2014;2: 366–374. [Google Scholar]
  • 27.Whelton PK, Carey RM, Aronow WS. Acc/aha/aapa/abc/acpm/ags/APhA/ASH/ASPC/nma/pcna guideline for the prevention, Detection, evaluation, and management of high blood pressure in adults: a Report of the American College of Cardiology/American heart Association. Task force on clinical practi. Почки. 2018;7. [DOI] [PubMed] [Google Scholar]
  • 28.Organization WH. World Health Organization: definition and diagnosis of diabetes mellitus and intermediate hyperglycemia: report of a WHO/IDF consultation. 2006. [Google Scholar]
  • 29.Kibria GM Al. Prevalence and Factors Associated with Diabetes among Bangladeshi Adults: An Analysis of Demographic and Health Survey 2017–18. Diabetes Epidemiol Manag. 2021;2: 100012. doi: 10.1016/j.deman.2021.100012 [DOI] [Google Scholar]
  • 30.Talukder A, Hossain MZ. prevalence of Diabetes Mellitus and its Associated factors in Bangladesh: Application of two-level Logistic Regression Model. Sci Rep. 2020;10: 1–7. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 31.Al-Zubayer MA, Ahammed B, Sarder MA, Kundu S, Majumder UK, Islam SMS. Double and triple burden of non-communicable diseases and its determinants among adults in Bangladesh: Evidence from a recent demographic and health survey. Int J Clin Pract. 2021; 1–13. doi: 10.1111/ijcp.14613 [DOI] [PubMed] [Google Scholar]
  • 32.Kibria A, Muhammed G, Gupta R Das, Nayeem J. Prevalence, awareness, and control of hypertension among Bangladeshi adults: an analysis of demographic and health survey 2017–18. Clin Hypertens. 2021;27: 1–11. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 33.World Health Organization. BMI Classification 2019. 2019 [cited 18 Oct 2019]. Available: http://apps.who.int/bmi/index.jsp?introPage=intro_3.html
  • 34.Mahumud RA, Alam K, Dunn J, Gow J. The burden of chronic diseases among Australian cancer patients: Evidence from a longitudinal exploration, 2007–2017. PLoS One. 2020;15: 2007–2017. doi: 10.1371/journal.pone.0228744 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 35.Verry C, Sancey L, Dufort S, Le Duc G, Mendoza C, Lux F, et al. Treatment of multiple brain metastases using gadolinium nanoparticles and radiotherapy: NANO-RAD, a phase I study protocol. BMJ Open. 2019;9: e023591. doi: 10.1136/bmjopen-2018-023591 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 36.Vellakkal S, Subramanian S V, Millett C, Basu S, Stuckler D, Ebrahim S. Socioeconomic inequalities in non-communicable diseases prevalence in India: disparities between self-reported diagnoses and standardized measures. PLoS One. 2013;8: e68219. doi: 10.1371/journal.pone.0068219 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 37.Siegel KR, Patel SA, Ali MK. Non-communicable diseases in South Asia: contemporary perspectives. Br Med Bull. 2014;111: 31–44. doi: 10.1093/bmb/ldu018 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 38.Shah P, Rahman SA, Demirbilek H, Güemes M, Hussain K. Hyperinsulinaemic hypoglycaemia in children and adults. lancet Diabetes Endocrinol. 2017;5: 729–742. doi: 10.1016/S2213-8587(16)30323-0 [DOI] [PubMed] [Google Scholar]
  • 39.Ralston J, Smith SC Jr. Non-Communicable Disease Alliance Moving Forward: Follow-Up to the United Nations High-Level Meeting. Global Heart. No longer published by Elsevier; 2012. pp. 83–86. doi: 10.1016/j.gheart.2012.01.008 [DOI] [PubMed] [Google Scholar]
  • 40.Hasan M, Tasnim F, Tariqujjaman M, Ahmed S. Socioeconomic inequalities of undiagnosed diabetes in a resource-poor setting: Insights from the cross-sectional Bangladesh demographic and health survey 2011. Int J Environ Res Public Health. 2019;16: 115. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 41.Habib SH, Saha S. Burden of non-communicable disease: Global overview. Diabetes Metab Syndr Clin Res Rev. 2010;4: 41–47. doi: 10.1016/j.dsx.2008.04.005 [DOI] [Google Scholar]
  • 42.Gouda HN, Charlson F, Sorsdahl K, Ahmadzada S, Ferrari AJ, Erskine H, et al. Burden of non-communicable diseases in sub-Saharan Africa, 1990–2017: results from the Global Burden of Disease Study 2017. Lancet Glob Heal. 2019;7: e1375–e1387. doi: 10.1016/S2214-109X(19)30374-2 [DOI] [PubMed] [Google Scholar]
  • 43.Al-Daghri NM, Al-Attas OS, Alokail MS, Alkharfy KM, Yousef M, Sabico SL, et al. Diabetes mellitus type 2 and other chronic non-communicable diseases in the central region, Saudi Arabia (Riyadh cohort 2): a decade of an epidemic. BMC Med. 2011;9: 1–6. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 44.Ali N, Akram R, Sheikh N, Sarker AR, Sultana M. Sex-specific prevalence, inequality and associated predictors of hypertension, diabetes, and comorbidity among Bangladeshi adults: results from a nationwide cross-sectional demographic and health survey. BMJ Open. 2019;9: e029364. doi: 10.1136/bmjopen-2019-029364 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 45.Association AD. Physical activity/exercise and diabetes. Diabetes Care. 2004;27: s58–s62. doi: 10.2337/diacare.27.2007.s58 [DOI] [PubMed] [Google Scholar]
  • 46.Bureau of Statistics. Ministry of planning government of B. Bangladesh Statistics 2017. 2017.
  • 47.Shifti DM, Chojenta C, Holliday EG, Loxton D. Socioeconomic inequality in short birth interval in Ethiopia: a decomposition analysis. BMC Public Health. 2020;20: 1–13. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 48.Wagstaff A, O’Donnell O, Van Doorslaer E, Lindelow M. Analyzing health equity using household survey data: a guide to techniques and their implementation. World Bank Publications; 2007. [Google Scholar]
  • 49.Jann B. Estimating Lorenz and concentration curves. Stata J. 2016;16: 837–866. [Google Scholar]
  • 50.O’Donnell O, O’Neill S, Van Ourti T, Walsh B. Conindex: estimation of concentration indices. Stata J. 2016;16: 112–138. [PMC free article] [PubMed] [Google Scholar]
  • 51.Bredenkamp C, Wagstaff A, Buisman L, Prencipe L, Rohr D. Health Equity and Financial Protection Datasheets. Health Equity and Financial Protection Datasheets. 2012. doi: 10.1596/26869 [DOI] [Google Scholar]
  • 52.O’Donnell O. van Doorslaer E. Wagstaff A. Lindelow M(2008). Anal Heal equity using Househ Surv data A Guid to Tech their Implement. [Google Scholar]
  • 53.Di Cesare M, Khang Y-H, Asaria P, Blakely T, Cowan MJ, Farzadfar F, et al. Inequalities in non-communicable diseases and effective responses. Lancet. 2013;381: 585–597. doi: 10.1016/S0140-6736(12)61851-0 [DOI] [PubMed] [Google Scholar]
  • 54.Gupta R, Kaul V, Agrawal A, Guptha S, Gupta VP. Cardiovascular risk according to educational status in India. Prev Med (Baltim). 2010;51: 408–411. doi: 10.1016/j.ypmed.2010.08.014 [DOI] [PubMed] [Google Scholar]
  • 55.Costa G, Spadea T, Deboosere P, Borrell C, Valkonen T, Gisser R, et al. Socioeconomic status and ischaemic heart disease. Heart. 2006;92: 461–467. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 56.Sommer I, Griebler U, Mahlknecht P, Thaler K, Bouskill K, Gartlehner G, et al. Socioeconomic inequalities in non-communicable diseases and their risk factors: an overview of systematic reviews. BMC Public Health. 2015;15: 1–12. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 57.Hosseinpoor AR, Bergen N, Mendis S, Harper S, Verdes E, Kunst A, et al. Socioeconomic inequality in the prevalence of noncommunicable diseases in low-and middle-income countries: results from the World Health Survey. BMC Public Health. 2012;12: 1–13. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 58.Mahumud RA, Rahman MA, Gow J, Kamara JK, Koly KN, Shahjalal M, et al. The global and regional burden of sexual behaviors and food insecurity and their combined association on the magnitude of suicidal behaviors among 121,248 adolescent girls: An international observational study in 67 low- and middle-income and high-income. J Affect Disord. 2022;298: 481–491. doi: 10.1016/j.jad.2021.11.023 [DOI] [PubMed] [Google Scholar]
  • 59.Nujhat S, Alam W, Parajuli A, Mohsen WAM, Banyira L, Gupta R Das, et al. Prevalence of risk factors for non-communicable diseases in a rural population of Bangladesh: a cross-sectional study. Lancet Glob Heal. 2020;8: S21. doi: 10.1016/s2214-109x(20)30162-5 [DOI] [Google Scholar]
  • 60.Akter J, Shahjahan M, Hossain S, Chowdhury HA, Ahmed KR, Fatema K, et al. Determinants of overweight and obesity among Bangladeshi diabetic women of reproductive age. BMC Res Notes. 2014;7: 1–6. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 61.Mutyambizi C, Booysen F, Stokes A, Pavlova M, Groot W. Lifestyle and socio-economic inequalities in diabetes prevalence in South Africa: A decomposition analysis. PLoS One. 2019;14: e0211208. doi: 10.1371/journal.pone.0211208 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 62.Banik S, Rahman M. Prevalence of overweight and obesity in Bangladesh: a systematic review of the literature. Curr Obes Rep. 2018;7: 247–253. doi: 10.1007/s13679-018-0323-x [DOI] [PubMed] [Google Scholar]
  • 63.Hasan E, Khanam M, Shimul SN. Socio-economic inequalities in overweight and obesity among women of reproductive age in Bangladesh: a decomposition approach. BMC Womens Health. 2020;20: 1–11. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 64.Howlader MH, Roshid HO, Kundu S, Halder HR, Chanda SK, Rahman MA. Determinants associated with high-risk fertility behaviours among reproductive aged women in Bangladesh: a cross-sectional study. Reprod Health. 2022;19: 1–10. doi: 10.1186/s12978-022-01333-w [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 65.Hu K, Ding P, Wu Y, Tian W, Pan T, Zhang S. Global patterns and trends in the breast cancer incidence and mortality according to sociodemographic indices: an observational study based on the global burden of diseases. BMJ Open. 2019;9: e028461. doi: 10.1136/bmjopen-2018-028461 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 66.Khan MS, Naznin S, Halder HR, Khan U, Hossain MM, Siddiquee T. Examining the prevalence of hypertension by urban–rural stratification: A Cross-sectional study of nepal demographic and health survey. Asian J Soc Heal Behav. 2021;4: 15. [Google Scholar]
  • 67.Organization WH. Global action plan for the prevention and control of noncommunicable diseases 2013–2020. World Health Organization; 2013. [Google Scholar]

Decision Letter 0

Jennifer Annette Campbell

4 Jul 2022

PONE-D-22-09701Socioeconomic Inequalities in the Risk Factors of Noncommunicable diseases (Hypertension and Diabetes) Among Bangladeshi Population: Evidence based on population level data analysisPLOS ONE

Dear Dr. Rahman,

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

Please submit your revised manuscript by Aug 18 2022 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

Please include the following items when submitting your revised manuscript:

  • A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.

  • A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.

  • An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.

If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols.

We look forward to receiving your revised manuscript.

Kind regards,

Jennifer Annette Campbell

Academic Editor

PLOS ONE

Journal Requirements:

When submitting your revision, we need you to address these additional requirements.

1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at

https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and

https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf

2. Please provide additional details regarding participant consent. In the ethics statement in the Methods and online submission information, please ensure that you have specified what type you obtained (for instance, written or verbal, and if verbal, how it was documented and witnessed). If your study included minors, state whether you obtained consent from parents or guardians. If the need for consent was waived by the ethics committee, please include this information.

3. In your Data Availability statement, you have not specified where the minimal data set underlying the results described in your manuscript can be found. PLOS defines a study's minimal data set as the underlying data used to reach the conclusions drawn in the manuscript and any additional data required to replicate the reported study findings in their entirety. All PLOS journals require that the minimal data set be made fully available. For more information about our data policy, please see http://journals.plos.org/plosone/s/data-availability.

Upon re-submitting your revised manuscript, please upload your study’s minimal underlying data set as either Supporting Information files or to a stable, public repository and include the relevant URLs, DOIs, or accession numbers within your revised cover letter. For a list of acceptable repositories, please see http://journals.plos.org/plosone/s/data-availability#loc-recommended-repositories. Any potentially identifying patient information must be fully anonymized.

Important: If there are ethical or legal restrictions to sharing your data publicly, please explain these restrictions in detail. Please see our guidelines for more information on what we consider unacceptable restrictions to publicly sharing data: http://journals.plos.org/plosone/s/data-availability#loc-unacceptable-data-access-restrictions. Note that it is not acceptable for the authors to be the sole named individuals responsible for ensuring data access.

We will update your Data Availability statement to reflect the information you provide in your cover letter.

4. We note that you have stated that you will provide repository information for your data at acceptance. Should your manuscript be accepted for publication, we will hold it until you provide the relevant accession numbers or DOIs necessary to access your data. If you wish to make changes to your Data Availability statement, please describe these changes in your cover letter and we will update your Data Availability statement to reflect the information you provide.

5. We note you have included a table to which you do not refer in the text of your manuscript. Please ensure that you refer to Table 2 in your text; if accepted, production will need this reference to link the reader to the Table.

[Note: HTML markup is below. Please do not edit.]

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #1: Yes

Reviewer #2: Yes

Reviewer #3: Yes

Reviewer #4: Yes

**********

2. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: Yes

Reviewer #2: Yes

Reviewer #3: Yes

Reviewer #4: Yes

**********

3. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: Yes

Reviewer #2: Yes

Reviewer #3: Yes

Reviewer #4: Yes

**********

4. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: Yes

Reviewer #2: No

Reviewer #3: No

Reviewer #4: Yes

**********

5. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: 1. Did the author exclude hypertension cases with pregnancy? Because hypertension cases may resolve after childbirth.

2. Author may look at individual association between risk factors for hypertension and diabetes.

3. Some studies have showed higher hypertension rate in working people since most of current jobs are desk jobs. Author found in this study that people with jobs have decreased risk of hypertension and diabetes. This is an interesting area to explore, e.g. job nature, working hour. If not explored, dissimilarities like this can be included in the discussion section.

4. The discussion section of the article is not well organized. The primary focus of the research question is 'socioeconomic inequality'. Therefore, while writing the discussion section, author may organize it by socioeconomic factors.

5. Author may link the study finding with literature more rigorously.

6. The website provided in the data availability section (https://dhsprogram.com/) do not share data with third party without permission. Hence, it is advisable to make the dataset for diabetes and hypertension visible / available to the editor for credibility of the analysis.

Reviewer #2: Dear Author

I must appreciate you for writing a nice manuscript focusing on NCDs including Diabetes and Hypertension.

However, I have some suggestions regarding your manuscript from the point of view of a reviewer.

Abstract: Nice, simple, and highly expressible.

Background: Excellent

Methodology: Nicely discussed and statistically sound.

Results: The tables and figures were well interpreted. Some important variables (added salt, working environment, food habit, family history of NCDs, lifestyle, smoking, alcohol, tobacco, etc. ) regarding NCDs are missing here, however, these limitations are manageable during working with the secondary dataset. I would like to add here that there is huge room to improve in the linguistic section, especially in sentence making, parts of speech, and run-on sentences.

Discussion: The article was nicely discussed and compared with the other related published articles. I think that linguistic improvement is also necessary for this section. I shall hereby suggest taking help from the professional body.

Conclusion: Briefly, the entire article is reflected in this section.

I must be thanking you once again for preparing this manuscript and have good luck with your manuscript.

Best Wishes

Reviewer.

Reviewer #3: 1. The paper is not well written. Some sentences are long with limited references. The justification of the study is poorly written there is necessity and room for improvement.

2. Methods section:

1. Data source is described to be the DHS. A little more specific details of how the data were obtained, what procedures were followed and long with what, if, a letter was required and for which datasets/variables data was accessed and how long it took would give readers more picture of the DHS data access.

3.Results:

Informative a bit lengthy. Also could use language and editorial revisions. some of the sentences were too long and difficult to understand the intent.

4.Conclusion:

Nothing new is found requires major revision, appears too small. Suggest some recommendations.

Reviewer #4: Dear authors,

Thank you for the opportunity to review your manuscript. I found the paper to be generally well written, and the topic to be interesting. My comments/concerns with the current manuscript are noted below.

Main Comments:

Methods:

1. Study population and survey design – what were the inclusion criteria used in order to arrive at the 12,290 sample size? Also, please clarify whether this represents the weighted or unweighted sample size.

2. Outcome variables – what was the reason for merging the patients with prediabetes and those with diabetes? Please clarify this within the text.

3. (Major) Independent variables (page 4, first sentence) – the first sentence is missing a citation. Also, more details on the variables included are needed as they are of considerable importance to the interpretation of later findings.

a. I encourage you to consider adding a conceptual model section that clearly outlines the categories of variables that influence your outcome variables, and then to list/explain the variables you include in order to adjust for each of these effects/channels within the context of your study.

b. Page 5: why are you including age covariates among your independent variables? I ask this because the abstract and statistical analysis section notes that your outcomes are already age-standardized.

c. Are the “wealth status” categories based on pre-set cutoffs, or upon wealth deciles that you create form your data? Please clarify this within the text.

4. Statistical Analysis:

a. How was age standardization of the data done? Please consider adding details to an appendix.

b. Page 7: the reference numberings do not align with those within the reference section at the end, please correct this.

c. Page 7: the term elasticity is mentioned, but not defined. Please add definition and explanation of this measure.

Results:

5. Table 1: it is said that values within parathesis are “(unweighted)” counts, however, it seems that they are percentages. Please check these. If they are indeed supposed to represent unweighted counts then why are they in decimal form and not presented as integers?

6. Prevalence of diabetes and hypertension section -- Please ensure sentences are complete without the information within parathesis, and also check punctuation placement (see e.g. end of second sentence).

7. On page 10 it is stated that “with age, the rate of hypertension increased …”, but was the hypertension rate not already age-standardized? Please clarify if this is referring to the unstandardized hypertension rate.

8. Page 12: please clarify what tests the p-values correspond to. I.e., please clarify the null and alternative hypotheses for these values.

9. Page 15: here it is stated that: “The column 'Elasticity' indicates the amount of change in the dependent variable (socioeconomic inequality in hypertension and diabetes) that occurs when the explanatory factors change by one unit.”. Please define the term elasticity. If this is referring to the traditional use within economics, then this is a unit-less measure, and as such, the end of this sentence should be revised accordingly.

10. Results/Discussion: in presenting the main findings as percentages, it is important to: (a) provide additional details within the text on how these are computed within Table 4; and (b) clarify to readers that these do not necessarily sum to 100%. While this might be clear to practitioners of these methods, given the broad readership of PLOS One, I think it is important to explain this within the text to avoid confusion.

Minor Comments:

Background:

11. Page 2, paragraph 1: the last sentence is unclear and needs to be revised.

Methods:

12. Statistical Analysis – the sentence starting with “Then, we assessed hypertension’s age… “ is incomplete. Please revise.

Results:

13. All tables – please add footnotes with explanation of all abbreviations under the table.

Discussion/Conclusions:

14. Discussion – page 19, paragraph 2, first sentence: please clarify what is meant by “…significantly lower among the less socioeconomic conditions…”.

**********

6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: Yes: Ishrat Binte Aftab

Reviewer #2: Yes: Goutam Kumar Acherjya, Assistant Professor (Medicine), Jashore Medical College, Jashore, Bangladesh.

Reviewer #3: No

Reviewer #4: No

**********

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step.

Decision Letter 1

Jennifer Annette Campbell

9 Aug 2022

PONE-D-22-09701R1Socioeconomic Inequalities in the Risk Factors of Noncommunicable diseases (Hypertension and Diabetes) Among Bangladeshi Population: Evidence based on population level data analysisPLOS ONE

Dear Dr. Rahman,

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but still does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

==============================

Outstanding Edits Recommended Prior to Consideration: 

  • Reviewer 4's comments have not been adequately addressed. Specifically, we would like to see the following elements more carefully included in the manuscript: (1) additional details on certain data / measures / definitions are needed throughout; (2) the final (main) decomposition analyses depend on the variables included within the model, and as such, it seems particularly important for the authors to explain/motivate their choice of variables beyond what is currently done (it would additionally be beneficial for them to base these variable choices on a clear conceptual model/framework, somethings that is currently missing); (3) the interpretations of results are presented as percentages off of the overall CIX value, which needs to be clearly explained in order to avoid confusing many readers who might, for example, assume these sum to 100% (which they do not).

  • Please note that while reviewers commented on the manuscript being well written, the grammatical errors that currently exist throughout this manuscript have to be addressed before it can be considered for publication. In addition, please remove the first person tense. We invite you to visit the PLOS Writing Center for free resources found here: https://plos.org/resources/writing-center/?utm_medium=website&utm_source=journalsite&utm_campaign=writingcenter&utm_content=submissionguidelines 

  • Additional specific edits noted by the editor: 1) Patient centered language is needed. For example, Line 102 “80% of the diabetic people reside” is not appropriate. See https://doi.org/10.2337/dci17-0041 The Use of Language in Diabetes Care and Education. 2) Line 106, please provide the date of the recent nationwide survey with some explanation as to why there would be such a significant rise in prevelance. For example, does the methodology vary and therefore did not adequately capture prevalence? 3) Line 162, please use phrasing consistent with the dataset description for diabetes oral medications and site reference. 4)Line 174, grammar. Had no working…this description appears to be incomplete. 

==============================

Please submit your revised manuscript by September 1, 2022. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

Please include the following items when submitting your revised manuscript:

  • A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.

  • A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.

  • An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.

If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols.

We look forward to receiving your revised manuscript.

Kind regards,

Jennifer Annette Campbell, PhD, MPH 

Academic Editor

PLOS ONE

Journal Requirements:

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. We may reject papers that do not meet these standards.

If the language of a paper is difficult to understand or includes many errors, we may recommend that authors seek independent editorial help before submitting a revision. These services can be found on the web using search terms like “scientific editing service” or “manuscript editing service.”

[Note: HTML markup is below. Please do not edit.]

Reviewers' comments:

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step.

Decision Letter 2

Jennifer Annette Campbell

31 Aug 2022

PONE-D-22-09701R2Socioeconomic Inequalities in the Risk Factors of Noncommunicable Diseases (Hypertension and Diabetes) among Bangladeshi Population: Evidence Based on Population Level Data AnalysisPLOS ONE

Dear Dr. Rahman,

Thank you for submitting your manuscript to PLOS ONE. We appreciate your response to each concern and would like to consider for publication, however prior to moving forward there remain a few outstanding edits that are needed and are considered very minor. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised.

Please submit your revised manuscript by Oct 15 2022 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

Please include the following items when submitting your revised manuscript:

  • A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.

  • A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.

  • An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.

If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols.

We look forward to receiving your revised manuscript.

Kind regards,

Jennifer Annette Campbell, PhD, MPH

Academic Editor

PLOS ONE

Journal Requirements:

Please review your reference list to ensure that it is complete and correct. If you have cited papers that have been retracted, please include the rationale for doing so in the manuscript text, or remove these references and replace them with relevant current references. Any changes to the reference list should be mentioned in the rebuttal letter that accompanies your revised manuscript. If you need to cite a retracted article, indicate the article’s retracted status in the References list and also include a citation and full reference for the retraction notice.

Additional Editor Comments:

Introduction:

Line 93

Please rephrase to “…80% of people living with diabetes reside in…”

Line 99

Please rephrase to “Due to demographic transitions and….”

Methods:

Line 122 - BDHS spell out initially 

Line 155 – Change “considered diabetes” to “….were classified as having diabetes” 

Statistical Analysis

Line 189-191

Please change this statement to read:  “As a result, the prevalence of hypertension and diabetes were normalized in the same standard population in order to eliminate or reduce the effect of participant age and sex distribution discrepancies.”

Line 193-194

Please change this statement to this statement: “Following that, a log-binomial regression model with survey weights and explanatory variables with p-values (0.05) was used…”

Line 224

Please add “the”: Among the population…

Results

Line 280 

Please rephrase to: “A total of 12,290 were included in the final analysis.”

Line 288

Please do not use the word objects to refer to human subjects. Please rephrase to “…among the sample population” 

Line 290 refers to “women” the preceding sections refer to “females”. For consistency please refer to all as “women” throughout the manuscript. 

Line 307 please correct, current sentence states “log binomial passion” 

Line 365 refers to diabetes and prediabetes. The manuscript as a whole is focused on diabetes and hypertension. Please address if prediabetes is also being examined. 

Line 435 please remove “to” from this sentence so that it reads, “may be responsible…”

Line 437 please add “are” so that this sentence reads “…hypertension and diabetes are significantly lower…”

Line 443-444 please address grammar by rephrasing to: “While overweight and obesity are risk factors for hypertension and diabetes…”

Line 471-472 please address grammar by rephrasing to: “Another factor contributing to overweight and obese…”

Line 492, pattern is used twice. Please remove duplicate. 

Line 510, please address, is this referring to plural studies or one study. If plural, please state “Previous studies have tried...” If singular, please state, “A previous study tried…” please add references to site which prior studies have tried. 

Line 528, please address grammar by stating: “The present study concludes….”

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step.

Decision Letter 3

Jennifer Annette Campbell

8 Sep 2022

Socioeconomic Inequalities in the Risk Factors of Noncommunicable Diseases (Hypertension and Diabetes) among Bangladeshi Population: Evidence Based on Population Level Data Analysis

PONE-D-22-09701R3

Dear Dr. Rahman,

We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements.

Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication.

An invoice for payment will follow shortly after the formal acceptance. To ensure an efficient process, please log into Editorial Manager at http://www.editorialmanager.com/pone/, click the 'Update My Information' link at the top of the page, and double check that your user information is up-to-date. If you have any billing related questions, please contact our Author Billing department directly at authorbilling@plos.org.

If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org.

Kind regards,

Jennifer Annette Campbell, PhD, MPH

Academic Editor

PLOS ONE

Additional Editor Comments (optional):

Reviewers' comments:

Acceptance letter

Jennifer Annette Campbell

12 Sep 2022

PONE-D-22-09701R3

Socioeconomic Inequalities in the Risk Factors of Noncommunicable Diseases (Hypertension and Diabetes) among Bangladeshi Population: Evidence Based on Population Level Data Analysis

Dear Dr. Rahman:

I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now with our production department.

If your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information please contact onepress@plos.org.

If we can help with anything else, please email us at plosone@plos.org.

Thank you for submitting your work to PLOS ONE and supporting open access.

Kind regards,

PLOS ONE Editorial Office Staff

on behalf of

Dr. Jennifer Annette Campbell

Academic Editor

PLOS ONE

Associated Data

    This section collects any data citations, data availability statements, or supplementary materials included in this article.

    Supplementary Materials

    Attachment

    Submitted filename: Rebuttal.docx

    Attachment

    Submitted filename: Rebuttal.docx

    Attachment

    Submitted filename: Rebuttal.docx

    Data Availability Statement

    This study used publicly available Demographic and Health Surveys Program datasets from Bangladesh, which can be freely obtained from https://dhsprogram.com/. As a third party users the authors do not have permission to share the data.


    Articles from PLoS ONE are provided here courtesy of PLOS

    RESOURCES